How soaring demand for Ozempic and Wegovy is altering Denmark's economy

The success of weight-loss drugs in the United States, particularly Novo Nordisk's Wegovy and Ozempic, has led to a surge in sales and profits, driving an influx of US dollars into Denmark's economy and boosting the value of the Danish krone. As a result, Denmark's central bank is keeping interest rates low, leading to lower mortgage rates for Danish homeowners.

cnn.com

Relevant topic timeline:

8/25/2023

Weight-Loss Drug Wegovy Will Launch In More Countries Despite Ongoing Struggles Over Stellar Demand, CEO Says

Novo Nordisk plans to launch its weight-loss drug Wegovy in more countries, despite shortages caused by high demand, according to CEO Lars Fruergaard Jorgensen.

9/1/2023

Novo Nordisk briefly overtakes LVMH as Europe's most valuable company

Danish drugmaker Novo Nordisk briefly surpassed LVMH as Europe's most valuable listed company, driven by high demand for its diabetes and weight-loss drugs, while LVMH has been affected by concerns over the Chinese economy.

9/4/2023

Weight-Loss Drug Wegovy Launches In U.K. As Shares Of Drugmaker Novo Nordisk Hit New Peak

Novo Nordisk has launched its weight-loss drug Wegovy in the UK, but warns of ongoing supply shortages that may take years to resolve.

9/6/2023

Morning Bid: Shedding pounds, buying dollars

Investors are eagerly anticipating the release of Novo Nordisk's weight-loss injection in British stores, while Manchester United shares plummeted after reports of the club being taken off the market; meanwhile, the dollar is strengthening, oil prices are rising, and concerns about weak demand and China's economy persist.